with hypotension still had significantly (t = 2.6585; p < 0.02) increased SACE values, whereas in patients with normal or high blood pressure values SACE showed only a borderline, nonsignificant (t = 1.1851; p < 0.3) increase. Increased Serum Angiotensin-Converting Enzyme in End-Stage Renal Disease 249 Patel, R.; Ansari, A.: Serum angiotensin-converting enzyme activity in patients with chronic renal failure on long-term hemodialysis. Clinica chim. Acta 92: 491-495 (1979) . Lieberman, J.; Sastre, A.: Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann. intern. Med. 93: 825-826 (1980 26:207-210 (1979) . We conclude from our data that elevated S ACE values 2 will be frequently found in patients with endstage renal failure on maintenance hemodialysis treatment. However, this may only partially be due to kidney failure per se as has been proposed by Silverstein et al. [1] and by Patel and Ansari [2] . Our data presented above suggest 4 that both liver disease and hypotension, which are often found in the dialysis patient population, may be implicated in the development of high SACE values. The association of high SACE and hypotension is of special interest. Although this association may be far from causal 6 and rather circumstantial, the mechanism underlying this association merits further elucidation. In summary, our results may explain, why some authors [1,2] found elevated SACE activity in patients with renal failure, whereas others [3] did not. They do not explain, however, why two other groups of investigators [4, 5] found decreased 8 SACE activities in patients with renal disease.
